BusinessElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017By Nasdaq OMXFeb 9, 2018, 9:57 PM UTC
BusinessElite Pharmaceuticals, Inc. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018By Nasdaq OMXFeb 7, 2018, 12:00 PM UTC
BusinessElite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot StudyBy Nasdaq OMXJan 30, 2018, 1:36 PM UTC
BusinessElite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release GenericBy Nasdaq OMXJan 10, 2018, 1:02 PM UTC
BusinessElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017By Nasdaq OMXNov 9, 2017, 9:59 PM UTC
BusinessElite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017By Nasdaq OMXNov 7, 2017, 1:00 PM UTC
